Regulus Therapeutics Inc.
RGLS
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Regulus Therapeutics Inc. is a clinical-stage biopharmaceutical company whose core business is the discovery and development of oligonucleotide-based therapeutics. This business model is fundamentally dependent on animal testing to meet regulatory requirements for drug safety and efficacy. The company’s lead product candidate, RGLS8429 for autosomal dominant polycystic kidney disease (ADPKD), is currently in clinical trials, which followed extensive preclinical testing in animal models. As documented in its SEC filings and clinical trial registries, the submission of Investigational New Drug (IND) applications and the progression of its pipeline are contingent upon data derived from animal studies.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.